Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selective Mediterranean Diet in Primary Immune Thrombocytopenia
NCT07798050Not yet recruiting
- Sponsor
- Assiut University
- Start
- Sep 2026
- Primary completion
- Sep 2027
01
Overview
Randomised trial in immune thrombocytopenia (ITP) (2 arms), sponsored by Assiut University. Primary endpoints: Change in platelet count at 12 weeks and Change in bleeding severity score at 12 weeks. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT07798050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07798050.